|
|
DSpace at RU >
Search Results
Results 1-50 of 96.
Item hits:
| Full Text | Issue Date | Title | Author(s) |  | 2012 | Temporary antiretroviral treatment during primary HIV-1 infection has a positive impact on health-related quality of life: data from the Primo-SHM cohort study | Grijsen, M.; Koster, G.; van Vonderen, M.; Kasteren, M.E.E. van; Kootstra, G.; Steingrover, R.; de Wolf, F.; Prins, J.M.; Nieuwkerk, P.T.; Koopmans, P.P.; Bosch, M. |
| | 2012 | The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study | Collaboration, H.-C.; Koopmans, P.P.; Brouwer, A.M.; Dofferhoff, A.S.M.; Flier, M. van der; Groot, R. de; Hofstede, H.J.M. ter; Keuter, M.; Ven, A.J.A.M. van der |
| | 2012 | Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries. | Brouwer, A.E.; Koopmans, P.P.; Hofstede, H.J. ter; Keuter, M.; Ven, A.J. van der; Groot, R. de |
| | 2012 | Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort. | Lelyveld, S.F. van; Gras, L.; Kesselring, A.; Zhang, S.; Wolf, F. de; Wensing, A.M.; Hoepelman, A.I.; Brouwer, A.E.; Koopmans, P.P.; Keuter, M.; Ven, A.J.A.M. van der; Hofstede, H.J.M. ter; Groot, R. de |
| | 2012 | No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial. | Grijsen, M.L.; Steingrover, R.; Wit, F.W.; Jurriaans, S.; Verbon, A.; Brinkman, K.; Ende, M.E. van der; Soetekouw, R.; Wolf, F. de; Lange, J.M.A.; Schuitemaker, H.; Prins, J.M.; Koopmans, P.P. |
 | 2011 | Rhabdomyolysis in an HIV-infected patient with impaired renal function concomitantly treated with rosuvastatin and lopinavir/ritonavir | Kanter, C.T.M.M. de; Keuter, M.; Lee, M.J. van der; Koopmans, P.P.; Burger, D.M. |
| | 2011 | Impact of the HIV-1 env genetic context outside HR1-HR2 on resistance to the fusion inhibitor enfuvirtide and viral infectivity in clinical isolates | Baatz, F.; Nijhuis, M.; Lemaire, M.; Riedijk, M.; Wensing, A.M.; Servais, J.Y.; Ham, P.M. van; Hoepelman, A.I.; Koopmans, P.P.; Sprenger, H.G.; Devaux, C.; Schmit, J.C.; Perez Bercoff, D. |
| | 2011 | Ribavirin plasma concentration measurements in patients with hepatitis C: early ribavirin concentrations predict steady-state concentrations | Slavenburg, S.; Huntjens-Fleuren, H.W.; Dofferhoff, T.S.; Richter, C.; Koopmans, P.P.; Verwey-van Wissen, C.P.W.G.M.; Drenth, J.P.H.; Burger, D.M. |
| | 2011 | Lower mortality and earlier start of combination antiretroviral therapy in patients tested repeatedly for HIV than in those with a positive first test | Gras, L.; Sighem, A. van; Bezemer, D.; Smit, C.; Wit, F.; Wolf, F. de; Koopmans, P.P.; Groot, R. de; Keuter, M.; Ven, A.J.A.M. van der; Hofstede, H.J. ter; Flier, M. van der; Brouwer, A.M. |
| | 2011 | The comparison of the performance of two screening strategies identifying newly-diagnosed HIV during pregnancy | Boer, K.; Smit, C.; Flier, M. van der; Wolf, F. de; Koopmans, P.P.; Crevel, R. van; Eggink, A.J.; Groot, R. de; Keuter, M.; Post, F.; Ven, A.J.A.M. van der; Warris, A. |
| | 2011 | When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study | Cain, L.E.; Logan, R.; Robins, J.M.; Sterne, J.A.; Sabin, C.; Bansi, L.; Justice, A.; Goulet, J.; Sighem, A. van; Wolf, F. de; Bucher, H.C.; Wyl, V. von; Esteve, A.; Casabona, J.; Amo, J. del; Moreno, S.; Seng, R.; Meyer, L.; Perez-Hoyos, S.; Muga, R.; Lodi, S.; Koopmans, P.P.; Lanoy, E.; Flier, M. van der; Costagliola, D.; Hernan, M.A.; Groot, R. de; Hofstede, H.J.M. ter; Keuter, M.; Ven, A.J.A.M. van der |
 | 2011 | Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group | Benard, A.; Sighem, A. van; Taieb, A.; Valadas, E.; Ruelle, J.; Soriano, V.; Calmy, A.; Balotta, C.; Damond, F.; Brun-Vezinet, F.; Chene, G.; Matheron, S.; Koopmans, P.P.; Groot, R. de; Keuter, M.; Ven, A.J.A.M. van der; Hofstede, H.J.M. ter; Flier, M. van der; Brouwer, A.M.; Dofferhoff, A.S.M. |
| | 2010 | No changes in efavirenz plasma concentrations in HIV-infected patients who switch from Stocrin to Atripla. | Burger, D.M.; Luin, M. van; Bosch, M.; Ven, A.J.A.M. van der; Brouwer, A.M.; Keuter, M.; Dofferhoff, T.; Koopmans, P.P. |
| | 2010 | Reguliere bespreking van ernstige complicaties tijdens opname op een afdeling Interne Geneeskunde | Janssen, M.C.H.; Koopmans, P.P.; Gurp, P.J.M. van |
| | 2010 | Could differential virological characteristics account for ongoing viral replication and insidious damage of the brain during HIV 1 infection of the central nervous system? | Vissers, M.E.P.; Stelma, F.F.; Koopmans, P.P. |
| | 2010 | The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. | Ray, M.; Logan, R.; Sterne, J.A.; Hernadez-Diaz, S.; Robins, J.M.; Sabin, C.; Bansi, L.; Sighem, A. van; Wolf, F. de; Costagliola, D.; Lanoy, E.; Bucher, H.C.; Wyl, V. von; Esteve, A.; Casbona, J.; Amo, J. del; Moreno, S.; Justice, A.; Goulet, J.; Lodi, S.; Phillips, A.; Seng, R.; Meyer, L.; Perez-Hoyos, S.; Garcia de Olalla, P.; Hernan, M.A.; Koopmans, P.P.; Brouwer, A.M.; Groot, R. de; Hofstede, H.J.M. ter; Keuter, M.; Ven, A.J.A.M. van der |
| | 2010 | Transmission networks of HIV-1 among men having sex with men in the Netherlands. | Bezemer, D.; Sighem, A. van; Lukashov, V.V.; Hoek, L. van der; Back, N.; Schuurman, R.; Boucher, C.A.B.; Claas, E.C.; Boerlijst, M.C.; Coutinho, R.A.; Wolf, F. de; Koopmans, P.P.; Groot, R. de; Brouwer, A.M.; Hofstede, H.J.M. ter; Keuter, M.; Ven, A.J.A.M. van der |
| | 2010 | Abacavir/lamivudine/zidovudine maintenance after standard induction in antiretroviral therapy-naive patients: FREE randomized trial interim results. | Sprenger, H.G.; Langebeek, N.; Mulder, P.G.; Napel, C.H.H. ten; Vriesendorp, R.; Hoepelman, A.I.; Legrand, J.C.; Koopmans, P.P.; Kasteren, M.E.E. van; Bravenboer, B.; Kate, R.W. ten; Groeneveld, P.H.; Werf, T.S. van der; Gisolf, E.H.; Richter, C. |
| | 2009 | Should antiretroviral therapy for HIV infection be tailored for intracerebral penetration? | Koopmans, P.P.; Ellis, R.; Best, B.M.; Letendre, S. |
| | 2009 | Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. | Mocroft, A.; Sterne, J.A.; Egger, M.; May, M.; Grabar, S.; Furrer, H.; Sabin, C.; Fatkenheuer, G.; Justice, A.; Reiss, P.; Arminio Monforte, A. d'; Gill, J.; Hogg, R.; Bonnet, F.; Kitahata, M.; Staszewski, S.; Casabona, J.; Harris, R.; Saag, M.; Koopmans, P.P.; Crevel, R. van; Groot, R. de; Keuter, M.; Post, F.; Ven, A.J.A.M. van der; Warris, A. |
| | 2008 | A patient with abdominal pain and a rash. | Laarhoven, H.W.M. van; Blokx, W.A.M.; Seyger, M.M.B.; Koopmans, P.P. |
| | 2008 | Toxic lopinavir concentrations in an HIV-1 infected patient taking herbal medications. | Beukel, C.J. van den; Bosch, M.E.; Burger, D.M.; Koopmans, P.P.; Ven, A.J.A.M. van der |
| | 2008 | Stavudine plasma concentrations and lipoatrophy. | Hofstede, H.J.M. ter; Koopmans, P.P.; Burger, D.M. |
| | 2008 | The effect of cholecalciferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D-deficient HIV-1-infected patients. | Beukel, CJ van den Bout-va; Bos, M.; Oyen, W.J.G.; Hermus, A.R.M.M.; Sweep, F.C.; Tack, C.J.J.; Bosch, M.E.; Burger, D.M.; Koopmans, P.P.; Ven, A.J.A.M. van der |
| | 2008 | High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets. | Nijland, H.M.J.; L'homme, R.F.A.; Rongen, G.A.P.J.M.; Uden, P. van; Crevel, R. van; Boeree, M.J.; Aarnoutse, R.E.; Koopmans, P.P.; Burger, D.M. |
| | 2008 | Evaluation of cytotoxic, genotoxic and CYP450 enzymatic competition effects of Tanzanian plant extracts traditionally used for treatment of fungal infections. | Beukel, CJ van den Bout-va; Hamza, O.J.; Moshi, M.J.; Matee, M.I.N.; Mikx, F.; Burger, D.M.; Koopmans, P.P.; Verweij, P.E.; Schoonen, W.G.; Ven, A.J.A.M. van der |
| | 2008 | Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. | Beukel, CJ van den Bout-va; Fievez, L.; Michels, M.; Sweep, F.C.; Hermus, A.R.M.M.; Bosch, M.E.; Burger, D.M.; Bravenboer, B.; Koopmans, P.P.; Ven, A.J.A.M. van der |
| | 2007 | Nieuw wapen in strijd tegen HIV. Maraviroc, de eerste CCR5-antagonist. | Hoorn, Y.H. van der; Burger, D.M.; Koopmans, P.P. |
| | 2007 | Darunavir (Prezista). Effectief bij resistentie tegen andere proteaseremmers. | Hoorn, Y.H. van der; Burger, D.M.; Koopmans, P.P. |
| | 2007 | Oral glucose loading for detection of mitochondrial toxicity during HAART in HIV-infected patients. | Hofstede, H.J.M. ter; Borm, G.F.; Koopmans, P.P. |
| | 2007 | Therapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practice. | Cleijsen, R.M.; Ende, M.E. van der; Kroon, F.P.; Lunel, F.V.; Koopmans, P.P.; Gras, L.; Wolf, F. de; Burger, D.M. |
| | 2007 | Interaction study of the combined use of paroxetine and fosamprenavir-ritonavir in healthy subjects. | Lee, M.J. van der; Blenke, A.A.M.; Rongen, G.A.; Wissen, C.P.W.G.M. van; Koopmans, P.P.; Pharo, C.; Burger, D.M. |
| | 2007 | Pharmacokinetics and pharmacodynamics of combined use of lopinavir/ritonavir and rosuvastatin in HIV-infected patients. | Lee, M. van der; Sankatsing, R.; Schippers, E.; Vogel, M.; Fatkenheuer, G.; Ven, A.J.A.M. van der; Kroon, F.; Rockstroh, J.K.; Wyen, C.; Baumer, A.; Groot, E. de; Koopmans, P.P.; Stroes, E.S.; Reiss, P.; Burger, D.M. |
| | 2006 | The genotypic inhibitory quotient and the (cumulative) number of mutations predict the response to lopinavir therapy. | Hoefnagel, J.G.; Lee, M.J. van der; Koopmans, P.P.; Schuurman, R.; Jurriaans, S.; Sighem, A.I. van; Gras, L.; Wolf, F. de; Galama, J.M.D.; Burger, D.M. |
| | 2006 | Possible drug-metabolism interactions of medicinal herbs with antiretroviral agents. | Beukel, C. van den; Koopmans, P.P.; Ven, A.J.A.M. van der; Smet, P.A.G.M. de; Burger, D.M. |
| | 2006 | Lopinavir/ritonavir reduces lamotrigine plasma concentrations in healthy subjects. | Lee, M.J. van der; Dawood, L.; Hofstede, H.J.M. ter; Graaff, M.J.A. de; Ewijk-Beneken Kolmer, E.W.J. van; Caliskan-Yassen, N.; Koopmans, P.P.; Burger, D.M. |
| | 2006 | A retrospective TDM database analysis of interpatient variability in the pharmacokinetics of lopinavir in HIV-infected adults. | Leur, M.R. van der; Burger, D.M.; Porte, C.J.L. la; Koopmans, P.P. |
| | 2005 | Fosamprenavir (Telzir). | Burger, D.M.; Blenke, A.A.M.; Koopmans, P.P. |
| | 2005 | Depressiviteit bij Hiv-patienten is te behandelen. Gelijktijdig gebruik van paroxetine en fosamprenavir + ritonavir. | Blenke, A.A.M.; Lee, M.J. van der; Verweij-van Wissen, C.P.W.G.M.; Rongen, G.A.; Koopmans, P.P.; Burger, D.M. |
| | 2005 | Role of the inhibitory quotient in HIV therapy. | Hoefnagel, J.G.; Koopmans, P.P.; Burger, D.M.; Schuurman, R.; Galama, J.M.D. |
| | 2005 | TDM: therapeutic drug measuring or therapeutic drug monitoring? | Droste, J.A.H.; Koopmans, P.P.; Hekster, Y.A.; Burger, D.M. |
| | 2005 | Pharmacokinetics of once-daily lopinavir/ritonavir and the influence of dose modifications. | Porte, C.J.L. la; Schippers, E.F.; Ende, M.E. van der; Koopmans, P.P.; Blok, W.L.; Kauffmann, R.H.; Kroon, F.P.; Burger, D.M. |
| | 2005 | Vincristine pharmacokinetics and response to vincristine monotherapy in an up-front window study of the Dutch Childhood Leukaemia Study Group (DCLSG). | Groninger, E.; Boer, T. de; Koopmans, P.P.; Uges, D.R.A.; Sluiter, W.J.; Veerman, A.; Kamps, W.; Graaf, S.S.N. de |
| | 2005 | Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naive adults: 48-week results from the Antiretroviral Regimen Evaluation Study (ARES). | Lowe, S.H.; Wensing, B.M.; Hassink, E.A.M.; Kate, R.W. ten; Richter, C.; Schreij, G.; Koopmans, P.P.; Juttmann, J.R.; Tweel, I. van de; Lange, J.M.A.; Borleffs, J.C. |
| | 2005 | Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteers. | Aarnoutse, R.E.; Kleinnijenhuis, J.; Koopmans, P.P.; Touw, D.J.; Wieling, J.; Hekster, Y.A.; Burger, D.M. |
| | 2005 | Pharmacokinetic interaction study of indinavir/ritonavir and the enteric-coated capsule formulation of didanosine in healthy volunteers. | Porte, C.J.L. la; Verweij-van Wissen, C.P.W.G.M.; Ewijk, N. van; Aarnoutse, R.E.; Koopmans, P.P.; Reiss, P.; Stek Jr, M.; Hekster, Y.A.; Burger, D.M. |
| | 2004 | Highly active antiretroviral therapy for HIV infection: lessons for the future. | Burger, D.M.; Ven, A.J.A.M. van der; Koopmans, P.P. |
| | 2004 | F-18-fluorodeoxyglucose positron emission tomography for visualization of lipodystrophy in HIV-infected patients. | Bleeker-Rovers, C.P.; Ven, A.J.A.M. van der; Zomer, B.; Geus-Oei, L.F. de; Smits, P.; Corstens, F.H.M.; Koopmans, P.P.; Oyen, W.J.G. |
| | 2004 | Ocular syphilis acquired through oral sex in two HIV-infected patients. | McCall, M.B.B.; Lith-Verhoeven, J.J. van; Crevel, R. van; Crama, N.; Koopmans, P.P.; Hoyng, C.B.; Ven, A.J.A.M. van der |
| | 2004 | Therapeutic drug monitoring of nelfinavir in pregnancy: a case report. | Burger, D.M.; Grintjes, K.J.; Lotgering, F.K.; Koopmans, P.P. |
1
2
next
|
